湖滨生物治疗 LKFT
$33.45 −$0.11 (-0.33%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $33.45 0.00%
开盘$32.30
昨收$33.56
当日区间$32.27 – $33.60
成交量374.1K
市值$2.20B
市盈率（TTM）3.3
股息率–
基本面
最新报告季度：Q2, ended Jun 2026 · 报告货币为EUR
营收€12.11M-81.5% YoY
营业利润-€43.51M+23.7% YoY
净利润€2.11M+102.0% YoY
摊薄每股收益€0.03+101.9% YoY
自由现金流-€34.12M+69.8% YoY
经营现金流-€34.09M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率97.5%
营业利润率61.6%
净利率60.2%
净资产收益率20.2%
资产收益率16.6%
投入资本回报率19.2%
流动比率32.84
负债/资产比率2.6%
现金及投资€2.24B
总负债€4.77M
净现金（净负债）€2.23B
营收构成
2025/FY 季度
按地区
该公司以本国货币报告财务数据，并非美元。以下数字均标注了实际货币单位，未自动换算。
利润表
| 项目 | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| 报告营业总收入 | €12.11M | €6.48M | €1.11B | €900.82M | €71.16M |
| 营业总收入 | €12.11M | €6.48M | €1.11B | €900.82M | €71.16M |
| 营业成本 | €9.15M | €4.80M | €29.74M | €455,000.00 | €10.85M |
| 毛利润 | €2.97M | €1.68M | €1.08B | €900.37M | €60.32M |
| 营业费用 | €46.48M | €65.39M | €581.12M | €141.57M | €101.99M |
| 销售及管理费用 | €7.51M | €35.51M | €111.96M | €2.94M | €46.42M |
| -销售及营销费用 | -€94,000.00 | €2.77M | €1.39M | -€3.01M | €3.88M |
| -管理费用 | €7.60M | €32.74M | €110.57M | €5.95M | €42.54M |
| 研发费用 | €25.52M | €30.96M | €459.42M | €107.51M | €73.88M |
| 其他营业费用 | €12.00M | -€1.08M | €254,000.00 | €21.63M | -€18.03M |
| 营业利润 | -€43.51M | -€63.70M | €501.39M | €758.80M | -€41.67M |
| 非经营性利息净收入（支出） | €12.65M | €13.42M | €45.19M | €14.75M | €9.27M |
| 非经营性利息收入 | €12.74M | €13.56M | €46.34M | – | – |
| 其他财务成本合计 | -€35,000.00 | €137,000.00 | -€1.07M | €29.38M | -€30.82M |
| 其他收入（支出） | €32.88M | €64.24M | -€245.71M | €9.61M | -€189.09M |
| 证券出售收益 | €32.88M | €64.24M | -€39.36M | €11.21M | €15.66M |
| 税前利润 | €2.01M | €13.96M | €300.87M | €783.16M | -€221.49M |
| 税费 | €70,000.00 | €70,000.00 | -€18.62M | €666,000.00 | -€17.50M |
| 净利润 | €2.11M | €14.49M | €320.88M | €782.15M | -€202.11M |
| 持续经营利润 | €1.94M | €13.89M | €319.49M | €782.49M | -€203.99M |
| 终止经营净利润 | €165,000.00 | €606,000.00 | €1.39M | -€343,000.00 | €1.88M |
| 归属母公司净利润 | €2.11M | €14.49M | €320.88M | €782.15M | -€202.11M |
| 归属普通股股东净利润 | €2.11M | €14.49M | €320.88M | €782.15M | -€202.11M |
| 基本每股收益 | €0.03 | €0.22 | €4.87 | €11.87 | -€3.07 |
| 摊薄每股收益 | €0.03 | €0.22 | €4.87 | €11.87 | -€3.07 |
| 折旧、摊销与折耗 | – | – | €9.49M | – | – |
| -折旧与摊销 | – | – | €9.49M | – | – |
| 非经营性利息支出 | – | – | €2.22M | – | – |
| 特殊收益（费用） | – | – | -€206.35M | -€1.60M | – |
| -减：重组及并购费用 | – | – | -€21.76M | – | – |
| -减：资本性资产减值 | – | – | €228.11M | €23.36M | – |
资产负债表
| 项目 | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| 总资产 | €3.35B | €3.37B | €3.41B | €3.41B | €3.51B |
| 流动资产合计 | €2.31B | €3.06B | €3.08B | €3.08B | €3.16B |
| 现金及现金等价物与短期投资 | €2.24B | €2.98B | €3.00B | €3.00B | €3.05B |
| -现金及现金等价物 | €135.95M | €66.81M | €87.87M | €87.87M | €64.46M |
| -短期投资 | €2.10B | €2.92B | €2.91B | €2.91B | €2.99B |
| 应收款 | €56.30M | €54.03M | €53.20M | €53.20M | €77.67M |
| -应收账款 | €23.70M | €21.74M | €9.57M | €9.57M | €45.33M |
| -其他应收款 | €32.60M | €32.30M | €43.64M | €43.64M | €32.34M |
| 存货 | €8.54M | €17.69M | €22.49M | €22.49M | €22.95M |
| 其他流动资产 | €3.96M | €4.08M | – | – | €11.29M |
| 非流动资产合计 | €1.04B | €311.69M | €327.06M | €327.06M | €349.89M |
| 固定资产净值 | €76.89M | €76.95M | €80.66M | €80.66M | €105.62M |
| 投资及预付款 | €73.86M | €47.93M | €46.81M | €46.81M | €46.84M |
| -长期股权投资 | €73.86M | €47.93M | €46.81M | €46.81M | €46.84M |
| 一年以上应收账款 | €137.55M | €161.37M | €174.41M | €174.41M | €165.92M |
| 一年以上应收票据 | €62,000.00 | €21.58M | €21.18M | €21.18M | €20.77M |
| 商誉及其他无形资产 | €750.66M | €746,000.00 | €848,000.00 | €848,000.00 | €7.42M |
| -其他无形资产 | €750.66M | €746,000.00 | €848,000.00 | €848,000.00 | €7.42M |
| 一年以上递延资产 | €134,000.00 | €163,000.00 | €195,000.00 | €195,000.00 | €838,000.00 |
| 其他非流动资产 | €2.68M | €2.95M | €2.96M | €2.96M | €2.49M |
| 负债合计 | €87.56M | €119.06M | €170.65M | €170.65M | €1.06B |
| 流动负债合计 | €70.32M | €100.42M | €152.86M | €152.86M | €366.56M |
| 应付款 | €67.30M | €96.68M | €33.58M | €33.58M | €100.98M |
| -应付账款 | €66.35M | €95.77M | €32.62M | €32.62M | €100.63M |
| -应付税款合计 | €953,000.00 | €912,000.00 | €956,000.00 | €956,000.00 | €349,000.00 |
| 短期债务及融资租赁负债 | €1.59M | €1.58M | €1.73M | €1.73M | €1.74M |
| -一年内到期融资租赁负债 | €1.59M | €1.58M | €1.73M | €1.73M | €1.74M |
| 一年内预提费用 | €1.40M | €2.13M | €45.50M | €45.50M | €33.72M |
| 一年内递延负债 | €33,000.00 | €32,000.00 | €32,000.00 | €32,000.00 | €230.12M |
| 非流动负债合计 | €17.23M | €18.64M | €17.79M | €17.79M | €698.39M |
| 长期债务及融资租赁负债 | €4.77M | €4.85M | €5.19M | €5.19M | €5.76M |
| -长期融资租赁负债 | €4.77M | €4.85M | €5.19M | €5.19M | €5.76M |
| 其他非流动负债 | €12.46M | €13.79M | €12.60M | €12.60M | €24.21M |
| 股东权益合计 | €3.26B | €3.25B | €3.24B | €3.24B | €2.45B |
| 股东权益 | €3.26B | €3.25B | €3.24B | €3.24B | €2.45B |
| 股本 | €293.94M | €293.94M | €293.94M | €293.94M | €293.94M |
| -普通股 | €293.94M | €293.94M | €293.94M | €293.94M | €293.94M |
| 资本公积 | €2.74B | €2.74B | €2.74B | €2.74B | €2.74B |
| 留存收益 | €233.96M | €228.33M | €210.58M | €210.58M | -€577.74M |
| 减：库存股 | €6.08M | – | – | – | – |
| 不影响留存收益的损益 | €4.82M | -€5.89M | -€5.64M | -€5.64M | -€6.23M |
| 预付资产 | – | – | €103,000.00 | €103,000.00 | – |
| 受限现金 | – | – | €0.00 | €0.00 | €0.00 |
| 一年内递延资产 | – | – | €5.61M | €5.61M | – |
| -固定资产原值 | – | – | €140.28M | €140.28M | – |
| -累计折旧 | – | – | -€59.62M | -€59.62M | – |
| 一年以上预付资产 | – | – | €0.00 | €0.00 | – |
| -商誉 | – | – | €0.00 | €0.00 | €0.00 |
| 一年内应计费用 | – | – | €20,000.00 | €20,000.00 | – |
| 其他流动负债 | – | – | €38.90M | €38.90M | – |
| 一年以上递延负债 | – | – | €0.00 | €0.00 | €666.31M |
| 员工福利 | – | – | €0.00 | €0.00 | €2.11M |
现金流量表
| 项目 | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| 经营活动现金流 | -€34.09M | -€82.75M | -€257.46M | -€47.46M | -€62.61M |
| 持续经营经营活动现金流净额 | -€34.09M | -€82.75M | -€257.46M | -€47.46M | -€62.61M |
| 持续经营净利润 | €2.11M | €14.49M | €320.88M | €782.15M | -€202.11M |
| 其他非现金项目 | €47.63M | -€73.66M | -€100.84M | -€393.21M | €328.64M |
| 营运资金变动 | -€7.52M | -€35.44M | -€876.57M | -€813.79M | -€94.70M |
| -其他营运资金变动 | -€8.66M | -€35.44M | -€1.03B | -€963.04M | €17.64M |
| 投资活动现金流净额 | €101.42M | €61.50M | €288.81M | €72.62M | €56.74M |
| 持续经营投资活动现金流净额 | €101.42M | €61.50M | €288.81M | €72.62M | €56.74M |
| 固定资产购置及出售净额 | €1.05M | €1.19M | -€13.24M | -€1.22M | -€2.77M |
| 无形资产购置及出售净额 | €0.00 | €0.00 | -€155,000.00 | €0.00 | €0.00 |
| 业务购买及出售净额 | -€731.75M | €2.34M | €19.43M | €1.62M | €8.08M |
| 投资购置及出售净额 | €779.62M | €57.96M | €242.33M | €67.15M | €38.40M |
| 筹资活动现金流 | -€3.94M | -€510,000.00 | -€3.27M | -€405,000.00 | -€1.26M |
| 持续经营筹资活动现金流净额 | -€3.94M | -€510,000.00 | -€3.27M | -€405,000.00 | -€1.26M |
| 债务发行及偿还净额 | -€1.07M | -€510,000.00 | -€3.27M | -€405,000.00 | -€1.26M |
| 期末现金余额 | €135.95M | €66.81M | €87.87M | €87.87M | €64.46M |
| 现金净变动 | €63.39M | -€21.76M | €28.09M | €24.76M | -€7.13M |
| 期初现金余额 | €66.81M | €87.87M | €64.24M | €64.46M | €71.67M |
| 汇率变动影响 | €5.76M | €700,000.00 | -€4.46M | -€1.35M | -€86,000.00 |
| 自由现金流 | -€34.12M | -€82.87M | -€271.32M | -€49.07M | -€65.46M |
| 持续经营损益 | – | – | €17.68M | – | – |
| 折旧、折耗与摊销 | – | – | €55.88M | – | – |
| 递延税款 | – | – | -€18.14M | – | – |
| -应收款变动 | – | – | €86.59M | – | – |
| -存货变动 | – | – | €28.85M | – | – |
| -其他流动负债变动 | – | – | €33.81M | – | – |
| 其他投资变动净额 | – | – | -€20.00M | €0.00 | €0.00 |
暂无评论——快来第一个聊聊 LKFT。
登录后参与讨论。